No two people with cancer are alike.

Each individual patient’s circumstances, concerns, struggles and successes are as unique as their needs. The strength and bravery of these individuals inspire and compel us every day. Delivering on the unique needs of each person with cancer has been at the core of our oncology business since our inception, and it remains at the very heart of our commitment, research and outreach.

Our mission remains constant — we endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients.

We are working every day to achieve our aspiration to cure cancer. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, we are finding innovative ways to improve the treatment of cancer.


Takeda Oncology, the Global Oncology Business Unit of Takeda Pharmaceutical, is headquartered in Cambridge, Massachusetts.

In 2008, Takeda Pharmaceutical acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. Takeda Oncology brings together our ever-expanding Global Oncology Business, R&D and Drug Discovery units into a single unified operation.

Currently, Takeda Oncology includes hubs in ten countries: the United States, Japan, Germany, Spain & Portugal (Iberia), France, Italy, the United Kingdom/Ireland and Canada. With this structure in place, we are optimally organized to discover, develop and deliver best-in-class oncology therapies for patients around the world.

Alongside our boundary-pushing global R&D unit, Takeda Oncology’s proven commercialization capabilities allow us to quickly respond to the diverse and ever-changing needs of patients, healthcare providers and health systems around the world. We are a force of more than 2,000 dedicated oncology professionals, driven by a patient-focused entrepreneurial spirit and commitment to agility, even as our organization grows in size and scope.


Takeda Pharmaceutical is a research-based, global pharmaceutical company headquartered in Osaka, Japan. Established in 1781, Takeda has an impressive track record of over 200 years of dedication to improving people's health. An industry leader with pharmaceutical products marketed in more than 90 countries, Takeda strives to create better health and a brighter future for people around the world through progress in medicine made possible by developing superior pharmaceutical products.

Our passion for healthcare and commitment to improving lives will enable us to make the next 200 years healthier and brighter for people around the world.

Committed to improving health — With countless people in desperate need of new healthcare solutions, there's no time to waste. That's why we pursue innovative medicines, including high-quality branded generics, over-the-counter (OTC) medicines and life-saving vaccines: to help as many people as we can, as soon as we can.

Strength from diversity — A common set of values, called Takeda-ism, unites us. Using our diverse skills and ideas, we develop fresh solutions to meet the needs of people around the world. Each of us is empowered to act swiftly and decisively in our quest to improve quality of life.

Powered by passion — Our people are our greatest asset. Driven by a passion to learn and contribute more, we embrace new challenges with confidence and open minds. We are determined to lead the change for a better world by empowering our people to shine.


Located at our headquarters in Cambridge, Massachusetts our 1000 Cranes of Hope initiative is an award-winning monument that is filled with passion, legend and lives transformed. Unique in its quest, it actively enfolds our own life stories into a collective life story as we journey from care to cure.

When we unveiled the 1000 Cranes of Hope in 2009, the initiative and monument were created in honor of the Japanese tradition senbazuru. According to legend, a person who folds 1,000 origami cranes will be granted one wish, such as a long life or recovery from illness. Typically, communities and families come together to accomplish this paper masterpiece.
Every origami crane created in this act of devotion is more than an artistic expression — it becomes an individual story enfolded. When combined these small folded birds become symbolic of the larger narrative of all the life stories that have been transformed by a shared singular assertion: hope.